Insulet Newsroom

Insulet Is Maintained at Buy by TD Cowen

Dow JonesJan 3 10:48 ET

Insulet Analyst Ratings

BenzingaJan 3 10:38 ET

TD Cowen Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $324

Moomoo NewsJan 3 08:31 ET

TD Cowen Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $324

Moomoo NewsJan 2 23:32 ET

BTIG Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $300

Moomoo NewsDec 30, 2024 06:31 ET

BTIG Raises Price Target on Insulet to $300 From $270, Maintains Buy Rating

MT NewswiresDec 30, 2024 06:26 ET

Redburn Atlantic Raises Price Target on Insulet to $300 From $270, Keeps Buy Rating

MT NewswiresDec 18, 2024 10:49 ET

Insulet Is Maintained at Overweight by JP Morgan

Dow JonesDec 12, 2024 14:47 ET

Insulet Analyst Ratings

BenzingaDec 12, 2024 14:37 ET

J.P. Morgan Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $330

Moomoo NewsDec 12, 2024 07:31 ET

Morgan Stanley Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $317

Moomoo NewsDec 12, 2024 05:32 ET

Insulet's Strong International Performance and Optimistic Type 2 Diabetes Market Outlook Drive Positive Analyst Rating

TipRanksDec 12, 2024 05:28 ET

Citigroup Raises Price Target on Insulet to $310 From $283, Keeps Buy Rating

MT NewswiresDec 11, 2024 11:46 ET

Insulet Is Maintained at Overweight by Wells Fargo

Dow JonesDec 11, 2024 10:19 ET

Insulet Analyst Ratings

BenzingaDec 11, 2024 10:09 ET

Citi Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $310

Moomoo NewsDec 11, 2024 07:31 ET

Wells Fargo Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $305

Moomoo NewsDec 11, 2024 07:31 ET

Wells Fargo Keeps Their Buy Rating on Insulet (PODD)

TipRanksDec 11, 2024 07:02 ET

Jefferies Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $340

Moomoo NewsDec 10, 2024 08:34 ET

Insulet (PODD) Receives a Buy From Jefferies

TipRanksDec 10, 2024 08:22 ET